Final Results

Medcaw Investments Plc (LSE: MCI), a company listed on the Main Market of the London Stock Exchange, announces its audited financial results for the year ended 31 December 2025.

The Company's Annual Report and Accounts will be made available on the Company's website at www.medcaw-invest.com.

NOTE: Trading in the Company's shares is temporarily suspended pending publication of the AIM admission document and completion of the proposed Reverse Takeover of the Eagle Lake Gold Project. This announcement is made pursuant to the Company's obligations under the UK Listing Rules.

Key Points

During the Year:

• Loss before taxation of £144,478 (FY24: £432,360), a reduction of 67%, reflecting the elimination of impairment charges and the waiver of accrued director fees totalling £182,454
• Basic and diluted loss per share of 0.65p (FY24: 1.95p)
• Cash and cash equivalents of £320,829 at 31 December 2025 (FY24: £72,286)
• On 10 September 2025, the Company issued unsecured Convertible Loan Notes ("CLNs") with a total principal value of £550,000 to fund ongoing corporate costs and transaction expenses
• Board refined investment strategy toward natural resources, focusing on Tier 1 mining jurisdictions
• On 19 December 2025, the Company entered into binding heads of terms with Ulvestone Ltd for the proposed acquisition of 90% of the Eagle Lake Gold Project, located in Ontario, Canada, by way of Reverse Takeover ("RTO")

Post Year End:

• Work on the proposed RTO is progressing to plan. Further details of the RTO, including the Notice of General Meeting, will be set out in the Admission Document, which the Company will publish in due course.

Marcus Yeoman, Non-Executive Chairman of Medcaw Investments Plc commented "Following a challenging period, 2025 saw Medcaw take decisive steps to reposition the Company for growth. The Board believes that the proposed acquisition of the Eagle Lake Gold Project in Ontario, if completed, could represent a significant strategic pivot and provide shareholders with exposure to a quality gold asset in a Tier 1 mining jurisdiction. The proposed move to AIM would provide a more suitable platform to deliver long-term value, with access to a broader natural resources investor base. The Board is pleased with the progress being made and looks forward to updating shareholders further in due course."

Medcaw Investments Plc (LSE: MCI) is a UK company currently listed on the Main Market of the London Stock Exchange. The Company has agreed, subject to Shareholder approval and Admission, to acquire 90% of Wedgetail Mining Ltd, the holder of the Eagle Lake Gold Project in Ontario, Canada - 95 contiguous mining claims covering approximately 1,986 hectares in the Kenora Mining Division, prospective for orogenic gold mineralisation.

Chairman's Statement

We announced on 2 April 2025 that the Board determined the Company would not proceed with the proposed acquisition of Abyssinian Metals Limited ("AML") as announced on 7 July 2023. The Board reached this conclusion as a result of the ongoing dispute between AML and the Federal Democratic Republic of Ethiopia (including Oromia State), details of which were announced by Medcaw on 8 November 2024.

The Company's shares re-commenced trading on the London Stock Exchange on 2 April 2025.

On 19 December 2025, the Company announced binding heads of terms with Ulvestone Ltd for the proposed acquisition, by way of a Reverse Takeover, of 90% of Wedgetail Mining Ltd ("Wedgetail"), which holds 95 contiguous mining claims comprising the Eagle Lake Gold Project in the Kenora Mining Division, Ontario, Canada, covering approximately 1,986 hectares. The Project is located approximately 27 km west-southwest of Dryden and lies within a historically underexplored greenstone belt that is prospective for orogenic gold mineralisation. The proposed consideration of £4.17 million comprises £170,000 in cash and £4.0 million to be satisfied through the issue of 266,666,667 new ordinary shares at 1.5 pence per share.

The Proposals form part of a wider corporate reorganisation, comprising: (i) cancellation of the Company's listing on the Main Market of the London Stock Exchange; (ii) Admission of the enlarged group to trading on AIM; (iii); and a Placing to fund initial exploration activities and working capital. A Rule 9 Waiver under the City Code on Takeovers and Mergers may be required in connection with the issue of the Consideration Shares.

The proposed acquisition of the Eagle Lake Gold Project represents a significant step forward for Medcaw and signals the start of a more focused growth phase. In an environment of ongoing macro uncertainty, gold continues to demonstrate its defensive qualities, and Ontario offers a stable, mining-friendly jurisdiction with strong infrastructure and regulatory clarity.

The Board believes that combining a high-quality gold asset with a move to AIM will provide the Company with a clearer strategic direction, enhanced market profile and access to a broader natural resources investor base. Subject to completion of the transaction and associated fundraise, the Directors are confident the Company will be appropriately capitalised to advance the Eagle Lake Gold Project and drive the next stage of development.

I would like to thank our shareholders, fellow directors and colleagues for their continued support during this period of significant corporate activity.

Marcus Yeoman

Non-Executive Chairman

Statement of Comprehensive Income

For the Year Ended 31 December 2025

The statement has been prepared on the basis that all operations are continuing operations.

Statement of Financial Position

As at 31 December 2025

Caution regarding forward looking statements